Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review
Abstract Introduction Although the introduction of biologics and targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs) has reshaped the treatment paradigm for immune-mediated inflammatory diseases (IMIDs) such as psoriasis, oral conventional synthetic DMARDs (csDMARDs) remain the corne...
Saved in:
Main Authors: | Tyng-Shiuan Hsieh (Author), Tsen-Fang Tsai (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis
by: Yinan Huang, et al.
Published: (2023) -
Dyshidrotic bullous pemphigoid developing after Moderna mRNA-1273 vaccination
by: Tyng-Shiuan Hsieh, et al.
Published: (2023) -
A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis
by: Cecilia Bava, et al.
Published: (2019) -
Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis
by: Kemper Alex R, et al.
Published: (2012) -
Disease-modifying antirheumatic drugs - Old and new: A brief overview
by: Vidya Divakar Baliga, et al.
Published: (2019)